Story
LyondellBasell Stock Outpaces Dow Amid Divergent Recovery Bets

Shares of LyondellBasell (LYB) have significantly outperformed chemical industry peer Dow (DOW) this year, reflecting investor expectations for a more robust earnings recovery. An analysis by Investing.com shows LyondellBasell's stock has gained 45.6% year-to-date, while Dow has risen 30.4%, as of August 25, 2026.
Valuation Gap Widens
The performance gap is mirrored in the companies' forward-looking valuations, even as both navigate a deep cyclical downturn. According to the analysis, which uses fundamental data as of June 30, 2026, LyondellBasell trades at a more attractive valuation on several key metrics.
- Forward P/E Ratio: LYB at 7.1x versus DOW at 12.6x.
- Free Cash Flow Yield: LYB at 7.7% compared to DOW's 6.6%.
- Estimated Fair Value Upside: The analysis suggests a 16.2% potential upside for LYB, compared to 9.2% for DOW.
This valuation discount for LyondellBasell suggests the market is pricing in a faster and more substantial rebound in its profitability.
Navigating a Cyclical Trough
AdBoth chemical giants have experienced significant earnings erosion amid challenging market conditions. Both companies posted net losses in fiscal year 2025 and have seen their trailing price-to-earnings ratios turn negative. The downturn has been severe, with Dow's EBITDA falling 75% from $10.9 billion in 2021 to $2.7 billion in 2025. LyondellBasell saw a similar 74% drop, from $8.6 billion to $2.2 billion over the same period.
However, LyondellBasell appears to have weathered the downturn with more resilient fundamentals. It maintains a superior gross profit margin of 12.9% versus Dow's 9.8% and reported a smaller net loss of -$0.8 billion in 2025, compared to Dow's -$2.6 billion loss, according to the source data.
Contrasting Investment Cases
The data presents two distinct scenarios for investors considering the chemical sector's recovery. LyondellBasell's case is built on its stronger current profitability, higher free cash flow generation, and a more compelling forward valuation. Its less negative Return on Equity (ROE) of -2.3% compared to Dow's -7.9% further highlights its relative operational stability.
Conversely, Dow offers a slightly higher dividend yield of 4.5% versus LyondellBasell's 4.2% and trades at a deeper discount to its book value. The primary bull case for Dow hinges on a broad-based recovery in chemical demand. Its historically higher operating leverage could enable a sharper and more pronounced earnings rebound if the industry cycle turns decisively positive.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.